Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA. Groves MD, et al. Among authors: peterson p. Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):127-35. doi: 10.1016/s0360-3016(99)00122-4. Int J Radiat Oncol Biol Phys. 1999. PMID: 10477016 Clinical Trial.
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
Groves MD, Puduvalli VK, Chang SM, Conrad CA, Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen PY, Greenberg H, Abrey LE, DeAngelis LM, Hess KR, Lamborn KR, Prados MD, Yung WK. Groves MD, et al. Among authors: peterson p. J Neurooncol. 2007 Feb;81(3):271-7. doi: 10.1007/s11060-006-9225-y. Epub 2006 Sep 22. J Neurooncol. 2007. PMID: 17031561 Clinical Trial.
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD; North American Brain Tumor Consortium. Lamborn KR, et al. Neuro Oncol. 2008 Apr;10(2):162-70. doi: 10.1215/15228517-2007-062. Epub 2008 Mar 4. Neuro Oncol. 2008. PMID: 18356283 Free PMC article.
Between unity and disparity: current treatment protocols for common orofacial clefts in European expert centres.
van Roey VL, Mink van der Molen AB, Mathijssen IMJ, Akota I, de Blacam C, Breugem CC, Craveiro Matos EM, Dávidovics K, Dissaux C, Dowgierd K, Eberlinc A, Hakelius M, Heliövaara A, Hens GZ, Khonsari RH, Krimmel M, Lux S, Mark H, Mazzoleni F, Meazzini MC, Munill Ferrer M, Nienhuijs ME, Peterson P, Piacentile K, Rubio Palau J, Sylvester-Jensen HC, Zafra Vallejo V, Versnel SL. van Roey VL, et al. Among authors: peterson p. Int J Oral Maxillofac Surg. 2024 Dec 12:S0901-5027(24)00447-8. doi: 10.1016/j.ijom.2024.12.001. Online ahead of print. Int J Oral Maxillofac Surg. 2024. PMID: 39672735 Free article.
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial.
Ho PM, Glorioso TJ, Allen LA, Blankenhorn R, Glasgow RE, Grunwald GK, Khanna A, Magid DJ, Marrs JC, Novins-Montague S, Orlando S, Peterson P, Plomondon ME, Sandy LM, Saseen JJ, Trinkley KE, Vaughn S, Waughtal J, Bull S. Ho PM, et al. Among authors: peterson p. JAMA. 2024 Dec 2:e2421739. doi: 10.1001/jama.2024.21739. Online ahead of print. JAMA. 2024. PMID: 39621340
1,707 results